96 related articles for article (PubMed ID: 33597492)
1. Human leukocyte antigen (HLA) class II association in chronic hepatitis B patients with hepatocellular carcinoma in a Malay population: A pilot study.
Krishnan PB; Abdullah M; Hudu SA; Sekawi Z; Tan SS; Amin-Nordin S
Trop Biomed; 2019 Sep; 36(3):703-708. PubMed ID: 33597492
[TBL] [Abstract][Full Text] [Related]
2. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
[TBL] [Abstract][Full Text] [Related]
3. Association of polymorphisms of human leucocyte antigen-DQA1 and DQB1 alleles with chronic hepatitis B virus infection, liver cirrhosis and hepatocellular carcinoma in Chinese.
Liu C; Cheng B
Int J Immunogenet; 2007 Oct; 34(5):373-8. PubMed ID: 17845309
[TBL] [Abstract][Full Text] [Related]
4. Relationship of HLA-DRB1 alleles with hepatocellular carcinoma development in chronic hepatitis B patients.
Jin YJ; Shim JH; Chung YH; Kim JA; Choi JG; Park WH; Lee D; Lee YS; Kim SE; Kim SH; Yang SH
J Clin Gastroenterol; 2012; 46(5):420-6. PubMed ID: 22499074
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQA1 & DQB1 variants associated with hepatitis B virus-related chronic hepatitis, cirrhosis & hepatocellular carcinoma.
Karra VK; Chowdhury SJ; Ruttala R; Gumma PK; Polipalli SK; Chakravarti A; Kar P
Indian J Med Res; 2018 Jun; 147(6):573-580. PubMed ID: 30168489
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.
De Re V; Caggiari L; Talamini R; Crovatto M; De Vita S; Mazzaro C; Cannizzaro R; Dolcetti R; Boiocchi M
Hum Immunol; 2004 Nov; 65(11):1397-404. PubMed ID: 15556690
[TBL] [Abstract][Full Text] [Related]
7. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
8. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.
Jiang YG; Wang YM; Liu TH; Liu J
World J Gastroenterol; 2003 Oct; 9(10):2221-5. PubMed ID: 14562382
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
[TBL] [Abstract][Full Text] [Related]
10. HLA class II alleles in Chinese patients with hepatocellular carcinoma.
Donaldson PT; Ho S; Williams R; Johnson PJ
Liver; 2001 Apr; 21(2):143-8. PubMed ID: 11318984
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
[TBL] [Abstract][Full Text] [Related]
12. Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection.
Corghi DB; Gonçales NS; Marques SB; Gonçales FL
Braz J Med Biol Res; 2008 Oct; 41(10):884-9. PubMed ID: 18925312
[TBL] [Abstract][Full Text] [Related]
13. Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients.
Han YN; Yang JL; Zheng SG; Tang Q; Zhu W
World J Gastroenterol; 2005 Sep; 11(36):5721-4. PubMed ID: 16237774
[TBL] [Abstract][Full Text] [Related]
14. The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population.
Deng Y; Li P; Liu W; Pu R; Yang F; Song J; Yin J; Han X; Li C; Zhao J; Wang H; Cao G
J Viral Hepat; 2020 Nov; 27(11):1150-1161. PubMed ID: 32568442
[TBL] [Abstract][Full Text] [Related]
15. Curative effects of interferon-alpha and HLA-DRB1 -DQA1 and -DQB1 alleles in chronic viral hepatitis B.
Zang GQ; Xi M; Feng ML; Ji Y; Yu YS; Tang ZH
World J Gastroenterol; 2004 Jul; 10(14):2116-8. PubMed ID: 15237447
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients.
Pan N; Chen K; Qiu J; Sun H; Xu J; Miao F; Shi Q; Jiang W; Jin H; He Y; Xie W; Zhang J
Hum Immunol; 2013 Jun; 74(6):758-63. PubMed ID: 23459080
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
18. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a histocompatibility antigen related to hepatitis B virus in patients with hepatocellular carcinoma in the western Brazilian Amazon.
Chalub SR; da Silva RM; da Silva AP; de Aquino PF; Sadahiro A; Kalil AN
Genet Mol Res; 2013 Apr; 12(2):1336-46. PubMed ID: 23661457
[TBL] [Abstract][Full Text] [Related]
20. [Study on the polymorphisme of human leucocyte antigen-DRB1, -DQA1 and -DQB1 alleles in patients with hepatitis B].
Jiang YG; Wang YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):337-40. PubMed ID: 15231205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
